Home NDC 24208-002-02 VITRASE
Product NDC 24208-002
Requested package NDC 24208-002-02
11-digit product format 242080002
Labeler code 24208
Product ID 24208-002_22bb835d-0433-4e75-bada-5cb60113d298
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name hyaluronidase, ovine
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Bausch & Lomb Incorporated
Application BLA021640
Marketing category BLA
Marketing start 2005-02-01
Marketing end 0000-00-00
Substance HYALURONIDASE, OVINE
Active strength 200 [USP'U]/mL
Pharmacologic classes Endoglycosidase [EPC],Glycoside Hydrolases [CS]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HYALURONIDASE, OVINE ACTIVE INGREDIENT 64R4OHP8T0 VITRASE (HYALURONIDASE, OVINE) INJECTION, SOLUTION [BAUSCH & LOMB INCORPORATED] 1 HYALURONIDASE, OVINE ACTIVE MOIETY 64R4OHP8T0 VITRASE (HYALURONIDASE, OVINE) INJECTION, SOLUTION [BAUSCH & LOMB INCORPORATED] 1 LACTOSE INACTIVE INGREDIENT J2B2A4N98G VITRASE (HYALURONIDASE, OVINE) INJECTION, SOLUTION [BAUSCH & LOMB INCORPORATED] 1 POTASSIUM PHOSPHATE, DIBASIC INACTIVE INGREDIENT CI71S98N1Z VITRASE (HYALURONIDASE, OVINE) INJECTION, SOLUTION [BAUSCH & LOMB INCORPORATED] 1 POTASSIUM PHOSPHATE, MONOBASIC INACTIVE INGREDIENT 4J9FJ0HL51 VITRASE (HYALURONIDASE, OVINE) INJECTION, SOLUTION [BAUSCH & LOMB INCORPORATED] 1 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X VITRASE (HYALURONIDASE, OVINE) INJECTION, SOLUTION [BAUSCH & LOMB INCORPORATED] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 24208-002 VITRASE (HYALURONIDASE, OVINE) INJECTION, SOLUTION [BAUSCH & LOMB INCORPORATED] 8 Legacy NDC 20240530_21fbd12e-4a12-4ad1-ad01-964cd5ec9996.zip
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 021640 Vitrase hyaluronidase 351(a) Disc 2026-09-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 24208-002-02 24208000202 2 VIAL, SINGLE-USE in 1 CARTON (24208-002-02) > 1.2 mL in 1 VIAL, SINGLE-USE 2005-02-01 0000-00-00 No No Current